Physician profile
Daniela Salazar
NPI 1487286803
$1,343.45
in general payments reported to CMS, 2019-2025
11 companies · $874 in 2025
The $874 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $200 · 2023: $136 · 2024: $133 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,142 · Travel and Lodging: $1.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.29 |
| Travel and Lodging | $1.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $356.12 | 2022-2025 | Zepbound |
| Gilead Sciences, INC. | $243.54 | 2023-2025 | Yeztugo, Descovy |
| Solventum Corporation | $150.00 | 2025 | Prevena |
| Astrazeneca Pharmaceuticals LP | $136.88 | 2025 | Airsupra, Wainua |
| Dexcom, INC. | $119.80 | 2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Pfizer INC. | $113.61 | 2025 | |
| Abbvie INC. | $102.33 | 2022-2025 | |
| Intra-Sana Laboratories | $50.00 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Viiv Healthcare Company | $27.57 | 2023-2024 | Dovato |
| Ardelyx, INC. | $22.17 | 2022 | |
| Merck Sharp & Dohme LLC | $21.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Salazar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.